|
Name |
5-(hydroxymethyl)-1H-pyrrole-2-carbaldehyde
|
Molecular Formula | C6H7NO2 | |
IUPAC Name* |
5-(hydroxymethyl)-1H-pyrrole-2-carbaldehyde
|
|
SMILES |
C1=C(NC(=C1)C=O)CO
|
|
InChI |
InChI=1S/C6H7NO2/c8-3-5-1-2-6(4-9)7-5/h1-3,7,9H,4H2
|
|
InChIKey |
SRPREECLSOIPNK-UHFFFAOYSA-N
|
|
Synonyms |
5-(hydroxymethyl)-1H-pyrrole-2-carbaldehyde; 67350-50-9; CHEBI:604731; 5-(hydroxymethyl)pyrrole-2-carboxaldehyde; 2-amino-6-(2-formyl-5-hydroxymethyl-1-pyrrolyl)-hexanoic acid; Epitope ID:141491; 2-Formyl-5-hydroxymethylpyrrol; CHEMBL499556; SCHEMBL17712572; DTXSID60497250; MFCD18810197; ZINC14491618; SB62063; AS-50199; CS-0157346; EN300-364250; O11303; 1H-Pyrrole-2-carboxaldehyde,5-(hydroxymethyl)-(9ci); Q27225782
|
|
CAS | 67350-50-9 | |
PubChem CID | 12416228 | |
ChEMBL ID | CHEMBL499556 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 125.13 | ALogp: | -0.3 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 53.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 9 | QED Weighted: | 0.572 |
Caco-2 Permeability: | -4.524 | MDCK Permeability: | 0.00001460 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.025 |
Blood-Brain-Barrier Penetration (BBB): | 0.762 | Plasma Protein Binding (PPB): | 18.55% |
Volume Distribution (VD): | 1.017 | Fu: | 84.13% |
CYP1A2-inhibitor: | 0.294 | CYP1A2-substrate: | 0.103 |
CYP2C19-inhibitor: | 0.043 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.008 | CYP2C9-substrate: | 0.448 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.468 |
CYP3A4-inhibitor: | 0.007 | CYP3A4-substrate: | 0.167 |
Clearance (CL): | 6.49 | Half-life (T1/2): | 0.917 |
hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.085 |
Drug-inuced Liver Injury (DILI): | 0.091 | AMES Toxicity: | 0.043 |
Rat Oral Acute Toxicity: | 0.164 | Maximum Recommended Daily Dose: | 0.013 |
Skin Sensitization: | 0.205 | Carcinogencity: | 0.031 |
Eye Corrosion: | 0.119 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.969 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001019 | 0.389 | D0E9CD | 0.250 | ||||
ENC000005 | 0.282 | D05OIS | 0.231 | ||||
ENC000166 | 0.282 | D08ZEB | 0.191 | ||||
ENC000412 | 0.270 | D0Y7DP | 0.183 | ||||
ENC000748 | 0.268 | D07HBX | 0.182 | ||||
ENC000696 | 0.268 | D0C6OQ | 0.179 | ||||
ENC000068 | 0.250 | D01CRB | 0.176 | ||||
ENC000003 | 0.250 | D0V9EN | 0.176 | ||||
ENC000414 | 0.250 | D0S2BV | 0.175 | ||||
ENC004043 | 0.245 | D05EJG | 0.175 |